Histoepigenetic analysis of HPV- and tobacco-associated head and neck cancer identifies both subtype-specific and common therapeutic targets despite divergent microenvironments
暂无分享,去创建一个
[1] M. Forster,et al. Immune Checkpoint Inhibition in Head and Neck Cancer , 2018, Front. Oncol..
[2] M. Boutros,et al. β-catenin-independent regulation of Wnt target genes by RoR2 and ATF2/ATF4 in colon cancer cells , 2018, Scientific Reports.
[3] James S. Lawson,et al. Oncogenic Viruses and Breast Cancer: Mouse Mammary Tumor Virus (MMTV), Bovine Leukemia Virus (BLV), Human Papilloma Virus (HPV), and Epstein–Barr Virus (EBV) , 2018, Front. Oncol..
[4] Y. Okamoto,et al. Inhibition of integrin β1-mediated oncogenic signalling by the antitumor microRNA-29 family in head and neck squamous cell carcinoma , 2017, Oncotarget.
[5] T. McGaha,et al. Type I Interferon in Chronic Virus Infection and Cancer. , 2017, Trends in immunology.
[6] N. Wentzensen,et al. Somatic Host Cell Alterations in HPV Carcinogenesis , 2017, Viruses.
[7] J. Lunceford,et al. PD-L2 Expression in Human Tumors: Relevance to Anti-PD-1 Therapy in Cancer , 2017, Clinical Cancer Research.
[8] Seiji Nakamura,et al. Critical roles of Wnt5a-Ror2 signaling in aggressiveness of tongue squamous cell carcinoma and production of matrix metalloproteinase-2 via ΔNp63β-mediated epithelial-mesenchymal transition. , 2017, Oral oncology.
[9] Z. Herceg,et al. Unique DNA methylation signature in HPV-positive head and neck squamous cell carcinomas , 2017, Genome Medicine.
[10] Amy L. Olex,et al. Analysis of The Cancer Genome Atlas sequencing data reveals novel properties of the human papillomavirus 16 genome in head and neck squamous cell carcinoma , 2017, Oncotarget.
[11] M. Boutros,et al. Wnt signaling in cancer , 2016, Oncogene.
[12] A. Jemal,et al. Cancer statistics, 2017 , 2017, CA: a cancer journal for clinicians.
[13] Adrian V. Lee,et al. Epigenomic Deconvolution of Breast Tumors Reveals Metabolic Coupling between Constituent Cell Types. , 2016, Cell reports.
[14] D. Rieke,et al. Targeted Therapy of Head and Neck Cancer , 2016, Oncology Research and Treatment.
[15] A. Hakimi,et al. The head and neck cancer immune landscape and its immunotherapeutic implications. , 2016, JCI insight.
[16] P. Laurent-Puig,et al. Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression , 2016, Genome Biology.
[17] E. Mroz,et al. Intra-tumor heterogeneity in head and neck cancer and its clinical implications , 2016, World journal of otorhinolaryngology - head and neck surgery.
[18] Maureen A. Sartor,et al. Subtypes of HPV-Positive Head and Neck Cancers Are Associated with HPV Characteristics, Copy Number Alterations, PIK3CA Mutation, and Pathway Signatures , 2016, Clinical Cancer Research.
[19] Chao Li,et al. LY 6 K promotes cervical cancer growth , invasion and migration through regulating VEGFA , 2016 .
[20] J. Zucman‐Rossi,et al. Immune Contexture, Immunoscore, and Malignant Cell Molecular Subgroups for Prognostic and Theranostic Classifications of Cancers. , 2016, Advances in immunology.
[21] Tian Wang,et al. Critical genes in head and neck squamous cell carcinoma revealed by bioinformatic analysis of gene expression data. , 2015, Genetics and molecular research : GMR.
[22] A. Butte,et al. Systematic pan-cancer analysis of tumour purity , 2015, Nature Communications.
[23] Ash A. Alizadeh,et al. Abstract PR09: The prognostic landscape of genes and infiltrating immune cells across human cancers , 2015 .
[24] G. Sledge,et al. Targeted Therapy for Cancer in the Genomic Era. , 2015, Cancer journal.
[25] Chung-Pin Li,et al. Erlotinib is effective in pancreatic cancer with epidermal growth factor receptor mutations: a randomized, open-label, prospective trial , 2015, Oncotarget.
[26] Ruedi Aebersold,et al. A Mass Spectrometric-Derived Cell Surface Protein Atlas , 2015, PloS one.
[27] D. Cheresh,et al. Integrins and cancer: regulators of cancer stemness, metastasis, and drug resistance. , 2015, Trends in cell biology.
[28] J. Xiang,et al. HER2-directed therapy: current treatment options for HER2-positive breast cancer , 2015, Breast Cancer.
[29] Steven J. M. Jones,et al. Comprehensive genomic characterization of head and neck squamous cell carcinomas , 2015, Nature.
[30] F. Buonaguro,et al. Antigen-specific vaccines for cancer treatment , 2014, Human vaccines & immunotherapeutics.
[31] Thomas Lengauer,et al. Comprehensive Analysis of DNA Methylation Data with RnBeads , 2014, Nature Methods.
[32] Petar Stojanov,et al. Integrative and Comparative Genomic Analysis of HPV-Positive and HPV-Negative Head and Neck Squamous Cell Carcinomas , 2014, Clinical Cancer Research.
[33] William Lee,et al. Unraveling the molecular genetics of head and neck cancer through genome-wide approaches , 2014, Genes & diseases.
[34] E. Andres Houseman,et al. Reference-free cell mixture adjustments in analysis of DNA methylation data , 2014, Bioinform..
[35] E. Houseman,et al. Normal Cell-Type Epigenetics and Breast Cancer Classification: A Case Study of Cell Mixture–Adjusted Analysis of DNA Methylation Data from Tumors , 2014, Cancer informatics.
[36] Joel H. Saltz,et al. Research and applications: Cancer Digital Slide Archive: an informatics resource to support integrated in silico analysis of TCGA pathology data , 2013, J. Am. Medical Informatics Assoc..
[37] R. Ward,et al. The dual role of the novel Wnt receptor tyrosine kinase, ROR2, in human carcinogenesis , 2013, International Journal of Cancer.
[38] Thomas M. Harris,et al. Unique DNA Methylation Loci Distinguish Anatomic Site and HPV Status in Head and Neck Squamous Cell Carcinoma , 2013, Clinical Cancer Research.
[39] Ellen T. Gelfand,et al. The Genotype-Tissue Expression (GTEx) project , 2013, Nature Genetics.
[40] Yi Li,et al. A mixture model for expression deconvolution from RNA-seq in heterogeneous tissues , 2013, BMC Bioinformatics.
[41] A. Chatterjee,et al. Integrins and metastasis , 2013, Cell adhesion & migration.
[42] J. Khan,et al. Identification of Cell Surface Proteins as Potential Immunotherapy Targets in 12 Pediatric Cancers , 2012, Front. Oncol..
[43] Sukjoon Yoon,et al. The Regulatory Mechanism of the LY6K Gene Expression in Human Breast Cancer Cells* , 2012, The Journal of Biological Chemistry.
[44] J. Kao,et al. Recognizing and reversing the immunosuppressive tumor microenvironment of head and neck cancer , 2012, Immunologic Research.
[45] A. Funnell,et al. Holding Tight: Cell Junctions and Cancer Spread. , 2012, Trends in cancer research.
[46] Esther Kim,et al. Human papillomavirus and rising oropharyngeal cancer incidence in the United States. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[47] Ralf Herwig,et al. ConsensusPathDB: toward a more complete picture of cell biology , 2010, Nucleic Acids Res..
[48] K. Ang,et al. Human papillomavirus and survival of patients with oropharyngeal cancer. , 2010, The New England journal of medicine.
[49] Ashley L. Buchanan,et al. Docetaxel and irinotecan in recurrent or metastatic head and neck cancer , 2009, Cancer.
[50] A. Regev,et al. An embryonic stem cell–like gene expression signature in poorly differentiated aggressive human tumors , 2008, Nature Genetics.
[51] A. Cmelak,et al. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. , 2008, Journal of the National Cancer Institute.
[52] L. Turek,et al. P16INK4a expression, human papillomavirus, and survival in head and neck cancer. , 2008, Oral oncology.
[53] S. Keam,et al. Bevacizumab: a review of its use in metastatic colorectal cancer. , 2008, Drugs.
[54] Y. Miyagi,et al. Cancer-testis antigen lymphocyte antigen 6 complex locus K is a serologic biomarker and a therapeutic target for lung and esophageal carcinomas. , 2007, Cancer research.
[55] C. Ragin,et al. The Epidemiology and Risk Factors of Head and Neck Cancer: a Focus on Human Papillomavirus , 2007, Journal of dental research.
[56] A. Jemal,et al. Cancer Statistics, 2007 , 2007, CA: a cancer journal for clinicians.
[57] Pablo Tamayo,et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[58] M. Zanetti,et al. CD8 T cell priming by B lymphocytes is CD4 help dependent , 2005, European journal of immunology.
[59] M. Hellmich,et al. Comparison of different isolation techniques prior gene expression profiling of blood derived cells: impact on physiological responses, on overall expression and the role of different cell types , 2004, The Pharmacogenomics Journal.
[60] M. Daly,et al. PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes , 2003, Nature Genetics.
[61] G. Snow,et al. Characterization of the human Ly‐6 antigens, the newly annotated member Ly‐6K included, as molecular markers for head‐and‐neck squamous cell carcinoma , 2003, International journal of cancer.
[62] C. Fenoglio-Preiser,et al. beta-Catenin mutation is a frequent cause of Wnt pathway activation in gastric cancer. , 2002, Cancer research.
[63] A. Olshan,et al. Human Papillomavirus and head and neck cancer: Epidemiology and molecular biology , 1998, Head & neck.